International Islet Transplant Registry.International Islet Transplant Registry Newsletter5: 1; 1994.
2.
FlyeM.W.; DuffyB.; PhelanD.; RatnerL.E.; MohanakumarT.Protective effects of liver transplantation on a simultaneously transplanted kidney in a highly sensitized patient.Transplantation50: 10511054; 1990.
3.
LacyP.E.; HegreO.D.; Gerasimidi-VazeouA.; GentileF.T.; DionneK.E.Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets.Science254: 17821784; 1991.
4.
LanzaR.P.; BeyerA.M.; ChickW.L.Xenogeneic humoral responses to islets transplanted in biohybrid diffusion chambers.Transplantation57: 1371; 1994.
5.
ScharpD.W.Islet transplantation: Approaches to a clinical therapy. In: LevineB.A., ed. Perspectives in general surgery. 3rd ed. St.Louis, MO: Quality Medical Publishers;1992: 93105.
6.
ScharpD.W.; LacyP.E.; SantiagoJ.V.; McCulloughC.S.; WeideL.G.; BoyleP.J.; FalquiL.; MarchettiP.; RicordiC.; GingerichR.L.Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.Transplantation51: 76; 1991.
7.
ScharpD.W.; LacyP.E.; SantiagoJ.V.; McCulloughC.S.; WeideL.G.; FalquiL.; MarchettiP.; GingerichR.L.; JaffeA.S.; CryerP.E.Insulin independence after islet transplantation into type I diabetic patient.Diabetes39: 515; 1990.
8.
ScharpD.W.; SwansonC.J.; OlackB.J.; LattaP.P.; HegreO.D.; DohertyE.J.; GentileF.T.; FlavinK.S.; AnsaraM.F.; LacyP.E.Protection of encapsulated human islets implanted without immunosuppression in patients with Type I and Type II diabetes and in nondiabetic controls.Diabetes43: 1167; 1994.
